-
EAU25 | Dr. Nikhil Mayor Presents NeuroSAFE PROOF Trial: Advancing Nerve-Sparing in Prostate Cancer Surgery
At #EAU25, Dr.Nikhil Mayor (Imperial College London) presented results from the NeuroSAFE PROOF trial (NCT03317990)—the first randomized, controlled, single-blinded study comparing NeuroSAFE-guided versus standard robot-assisted radical prostatectomy (RARP) in localized…
-
EAU25 | NeuroSAFE PROOF Trial: Enhancing Functional Outcomes in Prostate Cancer Surgery
At #EAU25, Dr. Ricardo Almeida Magana (UCL, London) presented compelling data from the NeuroSAFE PROOF trial, a multicenter, randomized phase 3 study evaluating the role of intraoperative frozen section analysis…
-
EAU25 | PERSIAN Trial: Can SBRT Enhance Systemic Therapy in Oligometastatic mHSPC?
At #EAU25, Dr. Giulio Francolini and colleagues presented early results from the ongoing PERSIAN trial (NCT03449719) a randomized phase II study investigating the addition of stereotactic body radiotherapy (SBRT) to…
-
EAU25 | PEACE-3 Trial Update: Bone-Protective Agents Improve Outcomes in mCRPC
At #EAU25, Dr. Fred Saad presented new insights from the PEACE-3 trial (NCT02194842), a multicenter study evaluating enzalutamide ± radium-223 in men with metastatic castration-resistant prostate cancer (mCRPC) and bone…
-
APASL 2025 Congress Chair: Dr. Lai Wei, Beijing Tsinghua Changgung Hospital
Highlights of the Congress The 34th Annual Meeting of the Asia-Pacific Association for the Study of the Liver (APASL) concluded successfully in Beijing on March 30, 2025. Under the theme…
-
EAU 2025 | Professors Dingwei Ye and Yijun Shen: Breakthrough Study on ADC Plus BCG for High-Risk NMIBC
Professor Dingwei Ye: Greetings to all readers of UroStream. I’m honored to have this opportunity to connect with Professor Yijun Shen during the EAU 2025 Confrence. As one of the…
-
EAU 2025 | 100% Specificity Achieved! Qilu Hospital of Shandong University’s “Non-Biopsy” Prostate Cancer Study Presented as Oral Report
Prostate biopsy remains the gold standard for diagnosing prostate cancer, but it carries risks such as infection, bleeding, and urinary obstruction. As a result, growing research interest has focused on developing “non-biopsy” diagnostic strategies. At the 2025 Annual Meeting of the European Association of Urology (EAU25), a study led by Professor Shouzhen Chen and Professor…
-
Professor Ying Fan Wins SGBCC Best Poster Award for Real-World Study on HER2-Positive Breast Cancer in the Neoadjuvant Setting
The 19th St. Gallen Breast Cancer Conference (SGBCC), held in Vienna from March 12 to 15, 2025, remains one of the most influential global platforms in early breast cancer care. Among seven studies awarded the prestigious Best Poster Award, four came from China, including a multi-center real-world study led by Professor Ying Fan from the…
Connecting Medical Expertise through Media